Diabetes Mellitus, Type 2: all 9,589 studies
Page 88 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 TreatmentCompletedNCT00696995
- Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial DysfunctionCompletedNCT00696722Phase 2
- Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of DiabetesCompletedNCT00696163
- Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 DiabetesCompletedNCT00695526Phase 3
- Vitamin D and Type 2 Diabetes - a Cross Sectional StudyCompletedNCT00695474
- Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 DiabetesStatus unknownNCT00694278
- Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes MellitusCompletedNCT00694057Phase 2
- Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed InsulinCompletedNCT00693771Phase 4
- Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery DiseaseCompletedNCT00693537Phase 4
- Circuit Training and Motivational Interviewing to Reduce Type 2 Diabetes in YouthCompletedNCT00693511Not applicable
- Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes MellitusCompletedNCT00690638Phase 3
- Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 DiabetesTerminatedNCT00690456Phase 3
- A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic PatientsCompletedNCT00690287Phase 1
- Longitudinal Cohort Study Comparing 2 Surgical Techniques in Patients With Class 3 Obesity and Type 2 DiabetesCompletedNCT00688974
- Blood Glucose Self Monitoring and HbA1c Effects on Glucose ControlCompletedNCT00688363Phase 4
- Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes MellitusCompletedNCT00687284
- Observational Study of Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNCT00687063
- A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to MetforminStatus unknownNCT00684528Phase 3
- English Diabetes Self-Management ProgramCompletedNCT00684086Not applicable
- A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00682097Phase 1
- Enhancing Support for Women With Type 2 Diabetes: Follow-UpCompletedNCT00680849
- The Acute Effect of Atorvastain on Renal Function in Patients With Type II DiabetesCompletedNCT00678522Phase 4
- A Diabetes Prevention Study Targeting High Risk Individuals With Education and Ongoing SupportCompletedNCT00677937Not applicable
- The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 DiabetesCompletedNCT00677599Not applicable
- Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCompletedNCT00676819Phase 4
- Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNCT00676741
- A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II DiabetesCompletedNCT00675857Phase 2
- Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30CompletedNCT00675493
- Remote Monitoring in Diabetes Disease ManagementCompletedNCT00675311Not applicable
- Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™CompletedNCT00675220
- Immune Profile and Complication Risk in Type 2 DiabetesStatus unknownNCT00674271
- A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 DiabetesCompletedNCT00672386Phase 2
- A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideCompletedNCT00671424Phase 1
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00671008
- Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinCompletedNCT00670722
- Observational Study of Patients With Diabetes Using Levemir® FlexPen®CompletedNCT00670683
- Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes MellitusCompletedNCT00668954Not applicable
- Type 2 Diabetes and Exercise - A Pilot StudyTerminatedNCT00666861
- A Randomized Controlled Trial of Exercise Training Among Men With Type 2-diabetesCompletedNCT00666094Not applicable
- Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in GermanyCompletedNCT00665808
- Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509CompletedNCT00665145Phase 2
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 DiabetesCompletedNCT00665093
- Glufast On Insulin Glargine Trial in Type 2 DMCompletedNCT00663884Phase 4
- A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes MellitusWithdrawnNCT00661921Phase 2
- Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 DiabetesCompletedNCT00660374Phase 2
- Dealing With Anxiety: A Cognitive Behavioural Program for DiabetesCompletedNCT00659932Not applicable
- Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)CompletedNCT00659477Phase 4
- Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of DiabetesCompletedNCT00659282
- Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®CompletedNCT00658099
- Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)CompletedNCT00657930
- Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® InsulinsCompletedNCT00657319
- Pioglitazone Incretin StudyCompletedNCT00656864Phase 4
- Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin GlargineTerminatedNCT00656422Phase 3
- Copenhagen Obesity Risk Assessment StudyCompletedNCT00655902Not applicable
- Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes MellitusStatus unknownNCT00655603Not applicable
- Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyStatus unknownNCT00655330Not applicable
- Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes MellitusCompletedNCT00655200
- Evaluation of Levemir® for the Treatment of Type 1 and 2 DiabetesCompletedNCT00655044
- Severe Insulin Resistance in Patients With Type 2 DiabetesCompletedNCT00654056Not applicable
- The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT00653510Not applicable
- Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)CompletedNCT00653341Phase 3
- Journey for Control of Diabetes Study (0431-111)CompletedNCT00652509Not applicable
- Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy SubjectsCompletedNCT00651105Phase 3
- Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic PatientsCompletedNCT00649909
- Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes SubjectsCompletedNCT00648284
- Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal InsufficiencyCompletedNCT00646542Phase 3
- A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 DiabetesCompletedNCT00645268Phase 4
- Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes MellitusCompletedNCT00644241Phase 2
- The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes PatientsCompletedNCT00643773Phase 2/3
- PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)CompletedNCT00643474Not applicable
- An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)CompletedNCT00642798Phase 1
- A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes MellitusCompletedNCT00642538Phase 1
- Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 DiabetesCompletedNCT00641407Phase 4
- DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass SurgeryCompletedNCT00641251Not applicable
- Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes MellitusTerminatedNCT00640549Phase 4
- Exploration of the Lipid Metabolism During the Diabetic PregnanciesCompletedNCT00639964Not applicable
- The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic HyperglucagonemiaCompletedNCT00639613
- Necessity for Lipid Lowering Therapy in Type 2 Diabetes PatientsCompletedNCT00639080
- The Incretin Effect in Patients With Chronic PancreatitisCompletedNCT00638573
- Single-Dose Study Of PF-04603629 In Type 2 Diabetic SubjectsCompletedNCT00638313Phase 1
- Gait and Balance of Diabetes Type 2 PatientsCompletedNCT00637546Phase 2/3
- Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes MellitusTerminatedNCT00637338Phase 1
- Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM)CompletedNCT00634673Not applicable
- Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 DiabetesTerminatedNCT00633997Phase 1/2
- A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna SR in Obese Type 2 DiabetesCompletedNCT00631774Not applicable
- Do You Need to Assess Myocardial Ischemia in Type 2 DiabetesTerminatedNCT00627783Not applicable
- Changes in Insulin Sensitivity After Weight LossCompletedNCT00627484
- Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)TerminatedNCT00627471Phase 4
- A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male SubjectsCompletedNCT00625859Phase 1
- Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 DiabetesCompletedNCT00624364Phase 4
- Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 DiabetesCompletedNCT00622960Phase 1
- Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino PatientsCompletedNCT00622323
- Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM PatientsTerminatedNCT00622089Phase 2/3
- A Study of ASP1941 in Participants With Type 2 Diabetes MellitusCompletedNCT00621868Phase 2
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesCompletedNCT00619697Phase 4
- Effect of PF-00734200 in Subjects With Type 2 DiabetesCompletedNCT00618007Phase 2
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal InsufficiencyCompletedNCT00616811Phase 3
- Effect of GSK376501 on CYP450 Activity in Healthy Adult SubjectsCompletedNCT00615212Phase 1
- Screening for Early Evidence of DiabetesCompletedNCT00614783